Diagnostic criteria of broad QRS complex tachycardia: decades of evolution

Authors, Journal, Affiliations, Type, DOI

Overview

This review traces the 45-year evolution of ECG criteria for differentiating ventricular tachycardia (VT) from supraventricular tachycardia (SVT) with aberrant conduction in broad QRS complex tachycardia (BCT). VT accounts for ~80% of all BCTs and carries the least favourable prognosis; misdiagnosis and treatment with agents such as verapamil or adenosine can cause severe haemodynamic deterioration and precipitate ventricular fibrillation. The review covers classical criteria (Sandler–Marriott 1965, Wellens 1978), the Brugada 4-step algorithm (1991), and the Vereckei aVR algorithm (2007/2008), with detailed discussion of limitations including BCT during antiarrhythmic drug treatment, bundle branch reentry tachycardia, fascicular VT, and pre-excited SVT. The authors conclude that combining three clinical criteria (any morphological criterion + AV dissociation + history of myocardial disease) achieves >95% PPV for VT, with procainamide as the preferred drug when diagnosis is uncertain.

Keywords

Broad QRS complex tachycardia, ventricular tachycardia, supraventricular tachycardia, AV dissociation, ECG algorithms, Brugada algorithm, Vereckei algorithm

Key Takeaways

History and Physical Examination

Atrioventricular Dissociation

Clinical detection of AV dissociation:

ECG detection of AV dissociation:

Echocardiographic detection:

Classical ECG Criteria

Sandler & Marriott (1965):

Marriott (1971):

Swanick et al. (1972):
Criteria favouring ventricular origin for right VEB vs SVT with LBBB:

  1. S-wave depth in V4 > S in V1
  2. Wide r-wave ≥0.03 s in lead V1
  3. Negative QRS polarity in lead I

Wellens classical criteria (1978):

The Brugada Algorithm (1991)

Analysed 554 BCTs; sensitivity 0.987, specificity 0.965:

Four sequential steps (applicable regardless of RBBB or LBBB morphology):

  1. Is there an RS complex in ANY precordial lead? If NO → diagnose VT
  2. Is the RS interval >100 ms in any precordial lead? If YES → diagnose VT
  3. Is AV dissociation present? If YES → diagnose VT
  4. Morphological criteria for VT in V1 and V6? If BOTH positive → VT; otherwise → SVT with aberrant conduction

The Vereckei aVR Algorithm (2007 and 2008)

Vereckei 2007 (287 patients; lead aVR + 12-lead):
Criteria for VT:

  1. Presence of AV dissociation
  2. Presence of an initial R-wave in lead aVR
  3. Vi/Vt ≤1 (initial 40 ms voltage / terminal 40 ms voltage)

Vereckei 2008 simplified — lead aVR only (313 patients):
Four criteria for VT in aVR (same accuracy as 2007 algorithm):

  1. Presence of an initial R-wave
  2. Width of initial r- or q-wave >40 ms
  3. Notching on the initial downstroke of a predominantly negative QRS complex
  4. Vi/Vt ≤1

Griffith Criteria (1991)

Multivariate analysis, 102 patients, 15 clinical + 11 ECG variables:
Independent predictors of VT:

  1. History of previous MI
  2. Lead aVF: predominantly negative deflection (especially with Q-wave in RBBB pattern); QS or qR in aVF in LBBB pattern highly suggestive of VT; Rs complex in aVF specific for SVT
  3. RBBB pattern: monophasic or biphasic V1 suggests VT; triphasic RSR'/rSR' configuration suggests SVT
  4. Axis change >40° between sinus rhythm and tachycardia

Predictive score: 0 criteria = almost certainly SVT; 1 = probably SVT; 2 = probably VT; 3–4 = almost certainly VT (accuracy 93%; 95% with independent P-wave activity + VEB morphology matching tachycardia)

Alberca Specificity Analysis (1997)

Of 12 morphological criteria, only 5 achieved >90% specificity (232 patients with SR + fixed intraventricular conduction delay):

  1. Rsr' or Rr' in V1 with RBBB morphology → specificity 98%
  2. QS, QR, or R pattern in V6 with RBBB morphology → specificity 98%
  3. Any Q in V6 with LBBB morphology → specificity 92%
  4. Concordant pattern in all precordial leads → specificity 100%
  5. Absence of RS complex in all precordial leads (especially useful for LBBB) → specificity 91%

Limitations of Morphological Criteria

BCT during antiarrhythmic drug treatment:

Bundle branch reentry tachycardia:

Fascicular ventricular tachycardia:

Pre-excited SVT:

ECG artefact:

Authors' Conclusion / Practical Approach

To achieve >95% PPV for VT, combine three criteria:

  1. Any morphological criterion (from Brugada, Vereckei, classical criteria)
  2. AV dissociation (detected clinically, by ECG, or echocardiographically)
  3. History of myocardial disease (MI, cardiomyopathy, congenital heart disease, previous surgery)

If diagnosis still uncertain AND typical BBB morphology absent → diagnose VT by default

Drug of choice when uncertain: procainamide (prolongs myocardial refractory period, AP refractory period, and retrograde fast AV nodal pathway — avoids potentially harmful drugs such as verapamil and adenosine in possible VT)

Limitations of the Document

Key Concepts Mentioned

Key Entities Mentioned

Wiki Pages Updated